{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T05:20:43Z","timestamp":1721193643609},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,24]]},"DOI":"10.7759\/cureus.19008","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T17:17:55Z","timestamp":1635095875000},"source":"Crossref","is-referenced-by-count":4,"title":["Severe Lactic Acidosis Due to Acute Intoxication by Emtricitabine\/Tenofovir Alafenamide"],"prefix":"10.7759","author":[{"given":"Swethapriya","family":"Chaparala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael C","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Paul","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1086\/518976","article-title":"A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa","volume":"45","author":"Bolhaar MG","year":"2007","unstructured":"Bolhaar MG, Karstaedt AS. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. Clin Infect Dis. 2007, 45:254-60. 10.1086\/518976","journal-title":"Clin Infect Dis"},{"key":"ref2","article-title":"Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria","volume":"10 Suppl 2","author":"Moyle G","year":"2005","unstructured":"Moyle G. Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria. Antivir Ther. 2005, 10 Suppl 2:M47-52.","journal-title":"Antivir Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1086\/521112","article-title":"Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary","volume":"196 Suppl 3","author":"Murphy RA","year":"2007","unstructured":"Murphy RA, Sunpath H, Kuritzkes DR, Venter F, Gandhi RT. Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary. J Infect Dis. 2007, 196 Suppl 3:S449-56. 10.1086\/521112","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1177\/135965350701200704","article-title":"Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors","volume":"12","author":"Venhoff N","year":"2007","unstructured":"Venhoff N, Setzer B, Melkaoui K, Walker UA . Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. Antivir Ther. 2007, 12:1075-85.","journal-title":"Antivir Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2004.09.010","article-title":"Fatal lactic acidosis associated with tenofovir and abacavir","volume":"9","author":"Giola M","year":"2005","unstructured":"Giola M, Basilico C, Grossi P. Fatal lactic acidosis associated with tenofovir and abacavir. Int J Infect Dis. 2005, 9:228-9. 10.1016\/j.ijid.2004.09.010","journal-title":"Int J Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective","volume":"2","author":"Lewis W","year":"2003","unstructured":"Lewis W, Day BJ, Copeland WC. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov. 2003, 2:812-22. 10.1038\/nrd1201","journal-title":"Nat Rev Drug Discov"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0102","article-title":"Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy","volume":"2","author":"Patel V","year":"2006","unstructured":"Patel V, Hedayati SS. Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy. Nat Clin Pract Nephrol. 2006, 2:109-14. 10.1038\/ncpneph0102","journal-title":"Nat Clin Pract Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3280b07b33","article-title":"The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years","volume":"21","author":"Nelson MR","year":"2007","unstructured":"Nelson MR, Katlama C, Montaner JS, et al.. The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. AIDS. 2007, 21:1273-81. 10.1097\/QAD.0b013e3280b07b33","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.11.1089.36138","article-title":"Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate","volume":"24","author":"Guo Y","year":"2004","unstructured":"Guo Y, Fung HB. Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate. Pharmacotherapy. 2004, 24:1089-94. 10.1592\/phco.24.11.1089.36138","journal-title":"Pharmacotherapy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1258\/0956462054944480","article-title":"Severe toxicity associated with the combination of tenofovir and didanosine: case report and review","volume":"16","author":"Masi\u00e1 M","year":"2005","unstructured":"Masi\u00e1 M, Guti\u00e9rrez F, Padilla S, Ramos JM, Pascual J. Severe toxicity associated with the combination of tenofovir and didanosine: case report and review. Int J STD AIDS. 2005, 16:646-8. 10.1258\/0956462054944480","journal-title":"Int J STD AIDS"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1086\/368313","article-title":"Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine","volume":"36","author":"Murphy MD","year":"2003","unstructured":"Murphy MD, O'Hearn M, Chou S. Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine. Clin Infect Dis. 2003, 36:1082-5. 10.1086\/368313","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12401","article-title":"The role of tenofovir alafenamide in future HIV management","volume":"17","author":"Antela A","year":"2016","unstructured":"Antela A, Aguiar C, Compston J, et al.. The role of tenofovir alafenamide in future HIV management. HIV Med. 2016, 17:4-16. 10.1111\/hiv.12401","journal-title":"HIV Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000392","article-title":"Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug","volume":"27","author":"Chan L","year":"2018","unstructured":"Chan L, Asriel B, Eaton EF, Wyatt CM. Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug. Curr Opin Nephrol Hypertens. 2018, 27:102-12. 10.1097\/MNH.0000000000000392","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002223","article-title":"Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials","volume":"33","author":"Gupta SK","year":"2019","unstructured":"Gupta SK, Post FA, Arribas JR, et al.. Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials. AIDS. 2019, 33:1455-65. 10.1097\/QAD.0000000000002223","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12960","article-title":"Tenofovir alafenamide associated fatal lactic acidosis in an autologous hematopoietic stem cell transplant recipient","volume":"20","author":"Alsunaid SR","year":"2018","unstructured":"Alsunaid SR, Ashraf H, Soubani AO. Tenofovir alafenamide associated fatal lactic acidosis in an autologous hematopoietic stem cell transplant recipient. Transpl Infect Dis. 2018, 20:e12960. 10.1111\/tid.12960","journal-title":"Transpl Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-015-0054-y","article-title":"Overdose of dolutegravir in combination with tenofovir disaproxil fumarate\/emtricitabine in suicide attempt in a 21-year old patient","volume":"12","author":"Lee M","year":"2015","unstructured":"Lee M, Eyer F, Felgenhauer N, Klinker HH, Spinner CD. Overdose of dolutegravir in combination with tenofovir disaproxil fumarate\/emtricitabine in suicide attempt in a 21-year old patient. AIDS Res Ther. 2015, 12:18. 10.1186\/s12981-015-0054-y","journal-title":"AIDS Res Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/00365540410027157","article-title":"Severe metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir","volume":"36","author":"Hansen AB","year":"2004","unstructured":"Hansen AB, Mathiesen S, Gerstoft J. Severe metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir. Scand J Infect Dis. 2004, 36:389-92. 10.1080\/00365540410027157","journal-title":"Scand J Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2009.142","article-title":"The nephrotoxic effects of HAART","volume":"5","author":"Izzedine H","year":"2009","unstructured":"Izzedine H, Harris M, Perazella MA. The nephrotoxic effects of HAART. Nat Rev Nephrol. 2009, 5:563-73. 10.1038\/nrneph.2009.142","journal-title":"Nat Rev Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001566","article-title":"Changes in kidney function associated with daily tenofovir disoproxil fumarate\/emtricitabine for HIV preexposure prophylaxis use in the United States Demonstration Project","volume":"77","author":"Tang EC","year":"2018","unstructured":"Tang EC, Vittinghoff E, Anderson PL, et al.. Changes in kidney function associated with daily tenofovir disoproxil fumarate\/emtricitabine for HIV preexposure prophylaxis use in the United States Demonstration Project. J Acquir Immune Defic Syndr. 2018, 77:193-8. 10.1097\/QAI.0000000000001566","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1310\/hct1506-246","article-title":"Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175)","volume":"15","author":"Touzard Romo F","year":"2014","unstructured":"Touzard Romo F, Smeaton LM, Campbell TB, et al.. Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175). HIV Clin Trials. 2014, 15:246-60. 10.1310\/hct1506-246","journal-title":"HIV Clin Trials"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007133","article-title":"Fatal lactic acidosis in hepatitis B virus-associated decompensated cirrhosis treated with tenofovir: a case report","volume":"96","author":"Jung TY","year":"2017","unstructured":"Jung TY, Jun DW, Lee KN, Lee HL, Lee OY, Yoon BC, Choi HS. Fatal lactic acidosis in hepatitis B virus-associated decompensated cirrhosis treated with tenofovir: a case report. Medicine (Baltimore). 2017, 96:e7133. 10.1097\/MD.0000000000007133","journal-title":"Medicine (Baltimore)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2016.08.010","article-title":"Rapid onset of fatal lactic acidosis complicating tenofovir therapy in a diabetic patient with cirrhosis: a cautionary tale","volume":"7","author":"Kumar R","year":"2017","unstructured":"Kumar R, Agrawal S. Rapid onset of fatal lactic acidosis complicating tenofovir therapy in a diabetic patient with cirrhosis: a cautionary tale. J Clin Exp Hepatol. 2017, 7:80-1. 10.1016\/j.jceh.2016.08.010","journal-title":"J Clin Exp Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-018-0773-3","article-title":"Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B","volume":"18","author":"Ying Y","year":"2018","unstructured":"Ying Y, Hu YK, Jin JL, Zhang JM, Zhang WH, Huang YX. Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B. BMC Gastroenterol. 2018, 18:45. 10.1186\/s12876-018-0773-3","journal-title":"BMC Gastroenterol"},{"key":"ref24","article-title":"Lactic acidosis complicating metformin and non-nucleoside reverse transcriptase inhibitor combination therapy: a smoldering threat in the post-HAART era","volume":"67","author":"Ortiz-Brizuela E","year":"2015","unstructured":"Ortiz-Brizuela E, P\u00e9rez-Patrigeon S, Recillas-Gispert C, G\u00f3mez-P\u00e9rez FJ. Lactic acidosis complicating metformin and non-nucleoside reverse transcriptase inhibitor combination therapy: a smoldering threat in the post-HAART era. Rev Invest Clin. 2015, 67:273-4.","journal-title":"Rev Invest Clin"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-6686.2011.00209.x","article-title":"Lactic acidosis after concomitant treatment with metformin and tenofovir in a patient with HIV infection","volume":"37","author":"Aperis G","year":"2011","unstructured":"Aperis G, Paliouras C, Zervos A, Arvanitis A, Alivanis P. Lactic acidosis after concomitant treatment with metformin and tenofovir in a patient with HIV infection. J Ren Care. 2011, 37:25-9. 10.1111\/j.1755-6686.2011.00209.x","journal-title":"J Ren Care"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.19546","article-title":"Fatal tenofovir-associateacd lactic acidosis: a case report","volume":"17","author":"Hashim H","year":"2015","unstructured":"Hashim H, Sahari NS, Sazlly Lim SM, Hoo FK. Fatal tenofovir-associateacd lactic acidosis: a case report. Iran Red Crescent Med J. 2015, 17:e19546. 10.5812\/ircmj.19546","journal-title":"Iran Red Crescent Med J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2174\/157488612805076534","article-title":"Combination therapy efavirenz\/emtricitabine\/tenofovir disoproxil fumarate associated with hepatic failure","volume":"7","author":"Qayyum S","year":"2012","unstructured":"Qayyum S, Dong H, Kovacic D, Sohail S, Waters B, Thornton C, Corbett CE. Combination therapy efavirenz\/emtricitabine\/tenofovir disoproxil fumarate associated with hepatic failure. Curr Drug Saf. 2012, 7:391-3. 10.2174\/157488612805076534","journal-title":"Curr Drug Saf"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000924","article-title":"Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis","volume":"29","author":"Triantos C","year":"2017","unstructured":"Triantos C, Kalafateli M, Aggeletopoulou I, et al.. Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis. Eur J Gastroenterol Hepatol. 2017, 29:998-1003. 10.1097\/MEG.0000000000000924","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008046","article-title":"Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: a case report","volume":"96","author":"Novick TK","year":"2017","unstructured":"Novick TK, Choi MJ, Rosenberg AZ, McMahon BA, Fine D, Atta MG. Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: a case report. Medicine (Baltimore). 2017, 96:e8046. 10.1097\/MD.0000000000008046","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/74866-severe-lactic-acidosis-due-to-acute-intoxication-by-emtricitabinetenofovir-alafenamide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:37Z","timestamp":1707507337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/74866-severe-lactic-acidosis-due-to-acute-intoxication-by-emtricitabinetenofovir-alafenamide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,24]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.19008","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,24]]}}}